0
Deep & Emerging Tech·August 4, 2026·1 min read

Lab Monkeys for $26,000 Show China’s Biotech Quest to Rival US

Share

Primate prices spiking to $26,000 in China highlight a hard biological bottleneck in drug development and a growing dependence on cross-border animal supply chains. Biotech operators should expect higher trial costs and timelines — and more pressure to validate AI-first or in vitro alternatives earlier in the pipeline.